Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disorders of Leukocytes01:27

Disorders of Leukocytes

851
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
851

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

DNA methylation-based classification of hematolymphoid neoplasms.

Blood advances·2026
Same author

Immune disparities in the TME of EBV+ and EBV- BL: role of reactive oxygen species generation pathways and platelet activation.

Blood advances·2026
Same author

Sweet stuff is dangerous in DLBCL.

Blood·2025
Same author

Gα<sub>i2</sub> Signaling Regulates Neonatal Respiratory Adaptation.

International journal of molecular sciences·2025
Same author

Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis.

The journal of pathology. Clinical research·2025
Same author

Atypical lymphoid proliferations associated with therapeutic intervention: a report of the 2024 EA4HP/SH lymphoma workshop.

Virchows Archiv : an international journal of pathology·2025

相关实验视频

Updated: Jun 4, 2025

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.7K

儿科淋巴瘤:概述和诊断挑战

John Kim Choi1, Leticia Quintanilla-Martinez2

  • 1Department of Pathology, The University of Alabama at Birmingham, WP P30N, 619 19Th Street South, Birmingham, AL, 35249-7331, USA. johnchoi@uabmc.edu.

Virchows Archiv : an international journal of pathology
|December 20, 2024
PubMed
概括

儿科淋巴瘤与成人类型不同,具有独特的亚型和遗传改变. 本次审查强调了2022年世界卫生组织的分类,重点关注诊断标准和儿童病例的更好的预后.

关键词:
IRF4 的重新安排.11q 改变 改变伯基特淋巴瘤是一种淋巴瘤EBV + 淋巴细胞扩散.霍奇金淋巴瘤是一种霍奇金淋巴瘤.儿科淋巴瘤 儿科淋巴瘤儿科类型的毛囊性淋巴瘤

更多相关视频

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.1K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

相关实验视频

Last Updated: Jun 4, 2025

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.7K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.1K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

科学领域:

  • 血液学 血液学 血液学
  • 儿科瘤学 儿科瘤学
  • 病理学 病理学 病理学

背景情况:

  • 儿科淋巴瘤很少见,仅占美国新诊断的10%.
  • 虽然诊断标准是共同的,但与成人形式相比,某些儿科淋巴瘤亚型存在显著差异.
  • 世界卫生组织 (WHO) 2022年分类现在包括针对儿科造血瘤的具体指导方针.

研究的目的:

  • 审查世卫组织对儿科淋巴瘤的分类.
  • 总结诊断标准,遗传发现和与成年同行之间的差异.
  • 讨论儿科淋巴瘤中新出现的亚型和诊断挑战.

主要方法:

  • 世界卫生组织 (WHO) 2022年儿童造血瘤分类的审查.
  • 对儿科淋巴瘤的诊断标准,遗传改变和预后因素的分析.
  • 儿科和成人淋巴瘤亚型的比较综述.

主要成果:

  • 儿科淋巴瘤经常表现出不同的频率,遗传突变和预后,通常有更好的结果.
  • 重新出现的B细胞淋巴瘤具有特定的基因变异 (例如,IRF4重排,11q增益/损失) 被突出显示.
  • 重叠的特征表明,儿科型卵泡淋巴瘤 (PTFL) 和儿科结节边缘区域淋巴瘤 (PNMZL) 可能代表一个单一的疾病谱.

结论:

  • 世卫组织2022年分类为了解儿科淋巴瘤提供了一个框架.
  • 基因洞察力和识别独特的亚型对于准确的诊断和管理至关重要.
  • 对EBV的作用和PTFL/PNMZL等新实体的进一步研究是有必要的.